These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12930368)

  • 1. Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection.
    Gregorio GV; Choudhuri K; Ma Y; Pensati P; Iorio R; Grant P; Garson J; Bogdanos DP; Vegnente A; Mieli-Vergani G; Vergani D
    Clin Exp Immunol; 2003 Sep; 133(3):404-13. PubMed ID: 12930368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mimicry between the hepatitis B virus DNA polymerase and the antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis B virus infection.
    Gregorio GV; Choudhuri K; Ma Y; Vegnente A; Mieli-Vergani G; Vergani D
    J Immunol; 1999 Feb; 162(3):1802-10. PubMed ID: 9973445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection.
    Gregorio GV; Pensati P; Iorio R; Vegnente A; Mieli-Vergani G; Vergani D
    Clin Exp Immunol; 1998 Jun; 112(3):471-6. PubMed ID: 9649217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of serum auto-antibodies in Chinese patients with chronic hepatitis C: negative role of serum viral titre and genotype.
    Luo JC; Hwang SJ; Li CP; Lu RH; Chan CY; Wu JC; Chang FY; Lee SD
    J Gastroenterol Hepatol; 1998 May; 13(5):475-9. PubMed ID: 9641643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-ENA antibody profile in hepatitis C patients undergoing hemodialysis.
    Batchoun RG; Al-Najdawi MA; Al-Taamary S
    Saudi J Kidney Dis Transpl; 2011 Jul; 22(4):682-8. PubMed ID: 21743211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease.
    Kerkar N; Choudhuri K; Ma Y; Mahmoud A; Bogdanos DP; Muratori L; Bianchi F; Williams R; Mieli-Vergani G; Vergani D
    J Immunol; 2003 Feb; 170(3):1481-9. PubMed ID: 12538711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays.
    Ali A; Nisar M; Idrees M; Rafique S; Iqbal M
    Int J Infect Dis; 2015 May; 34():84-9. PubMed ID: 25796431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition.
    Kammer AR; van der Burg SH; Grabscheid B; Hunziker IP; Kwappenberg KM; Reichen J; Melief CJ; Cerny A
    J Exp Med; 1999 Jul; 190(2):169-76. PubMed ID: 10432280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C.
    Muratori P; Muratori L; Guidi M; Granito A; Susca M; Lenzi M; Bianchi FB
    Clin Infect Dis; 2005 Feb; 40(4):501-7. PubMed ID: 15712070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile.
    Cassani F; Cataleta M; Valentini P; Muratori P; Giostra F; Francesconi R; Muratori L; Lenzi M; Bianchi G; Zauli D; Bianchi FB
    Hepatology; 1997 Sep; 26(3):561-6. PubMed ID: 9303483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of extractable nuclear antigens in childhood autoimmune liver disease.
    Gregorio GV; Davies ET; Mieli-Vergani G; Vergani D
    Clin Exp Immunol; 1995 Nov; 102(2):308-13. PubMed ID: 7586683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease.
    Muratori L; Lenzi M; Ma Y; Cataleta M; Mieli-Vergani G; Vergani D; Bianchi FB
    Gut; 1995 Sep; 37(3):406-12. PubMed ID: 7590439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological cross-reactivity to multiple autoantigens in patients with liver kidney microsomal type 1 autoimmune hepatitis.
    Choudhuri K; Gregorio GV; Mieli-Vergani G; Vergani D
    Hepatology; 1998 Nov; 28(5):1177-81. PubMed ID: 9794898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51.
    Bogdanos DP; Lenzi M; Okamoto M; Rigopoulou EI; Muratori P; Ma Y; Muratori L; Tsantoulas D; Mieli- Vergani G; Bianchi FB; Vergani D
    Int J Immunopathol Pharmacol; 2004; 17(1):83-92. PubMed ID: 15000871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
    Wu CH; Xu XY; Tian GS; Yu YY
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies in chronic hepatitis C virus infection and their association with disease profile.
    Williams MJ; Lawson A; Neal KR; Ryder SD; Irving WL;
    J Viral Hepat; 2009 May; 16(5):325-31. PubMed ID: 19302340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breaking self-tolerance toward cytochrome P4502E1 (CYP2E1) in chronic hepatitis C: possible role for molecular mimicry.
    Sutti S; Vidali M; Mombello C; Sartori M; Ingelman-Sundberg M; Albano E
    J Hepatol; 2010 Sep; 53(3):431-8. PubMed ID: 20576306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presentation of autoantibody to proliferating cell nuclear antigen in patients with chronic hepatitis B and C virus infection.
    Tzang BS; Chen TY; Hsu TC; Liu YC; Tsay GJ
    Ann Rheum Dis; 1999 Oct; 58(10):630-4. PubMed ID: 10491362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis for antibody cross-reactivity between the hepatitis C virus core protein and the host-derived GOR protein.
    Zhang ZX; Chen M; Wallhagen K; Trojnar J; Magnius LO; Wahren B; Sällberg M
    Clin Exp Immunol; 1994 Jun; 96(3):403-9. PubMed ID: 7516270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.